IP Verse

Treatment Regimen Utilizing Neratinib For Breast Cancer

Patent No. EP3000467 (titled "Treatment Regimen Utilizing Neratinib For Breast Cancer") was filed by Wyeth on Mar 24, 2010. The application was issued on Mar 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKDec 1, 2023ELKINGTON AND FIFE
ALFRED E TIEFENBACHERNov 28, 2023HAMM & WITTKOPP
HEXALNov 3, 2023ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3000467

WYETH
Application Number
EP15188350A
Filing Date
Mar 24, 2010
Status
Granted And Under Opposition
Jan 27, 2023
Publication Date
Mar 1, 2023
External Links
Slate, Register , Google Patents